25/02/2026
Monoclonal antibodies are a cornerstone of modern treatment. But what are they, exactly?
Antibodies are proteins the body produces to recognize and fight disease.
Monoclonal antibodies (mAbs) are laboratory-produced versions, designed to target a specific molecule in the body, such as part of cancer treatment, autoimmune therapy, and other advanced care.
Some monoclonal antibodies are classified as hazardous drugs.
Chemfort® CSTDs are designed for a wide range of hazardous drugs, including chemotherapy agents and biologics. They support closed handling from vial to vein across preparation and administration.
Because in hazardous drug handling, exposure risk is rarely limited to one step.
It can occur anywhere the process is not fully closed.
Learn more about safe handling of monoclonal antibodies: 🔗 https://www.simplivia.com/blog/safe-handling-of-monoclonal-antibodies-in-healthcare-settings/
—